Welcome to Francis Academic Press

Frontiers in Medical Science Research, 2023, 5(3); doi: 10.25236/FMSR.2023.050316.

Master Cao's Experience in Treating Lung Cancer


Xuejuan Zhai1, Yaohui Li2, Liping Cao2, Mian Chu2

Corresponding Author:
Yaohui Li

1Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, 712046, China

2Shaanxi Provincial Hospital of Chinese Medicine, Xi'an, Shaanxi, 710003, China


Objective: To explore the drug use law of Director Cao Liping in the treatment of lung cancer. Methods: 150 cases of medical records were collected and the characteristics of medication were analyzed with the help of "Traditional Chinese Medicine Inheritance Computing Platform (V3.0)".Results: The four Qi are mainly cold, warm and calm; The five flavors are mainly bitter, spicy and sweet; Meridians are mainly lung, spleen and stomach meridians; Its efficacy is mainly in resolving phlegm, relieving cough and asthma, tonifying deficiency and clearing heat. There are 26 drugs with frequency of more than 30 times, 41 groups of high-frequency drug combinations, and 4 groups of core prescriptions. Conclusion: The key of lung cancer is to strengthen the spleen and clear the lung, strengthen the spleen and clear the lung, supplement the deficiency and strengthen the right, and detoxify and remove the turbidity. The prescription can be used flexibly.


Lung cancer; Cao Liping; Traditional Chinese medicine inheritance computing platform; Law of drug use; Experience of famous doctors

Cite This Paper

Xuejuan Zhai, Yaohui Li, Liping Cao, Mian Chu. Master Cao's Experience in Treating Lung Cancer. Frontiers in Medical Science Research (2023) Vol. 5, Issue 3: 95-102. https://doi.org/10.25236/FMSR.2023.050316.


[1] Lin Lizhu, Wang Siyu, Huang Xuewu. Expert consensus on the diagnosis and treatment of lung cancer with integrated traditional and western medicine [J].Journal of TCM Oncology, 2021, 3(06): 1-17.

[2] Liu Zongchao, Li Zhexuan, Zhang Yang, et al. Interpretation of the Global Cancer Statistical Report in 2020 [J].Electronic Journal of Comprehensive Cancer Treatment, 2021, 7(02):1-14.

[3] Liang Di, Shi Jin, Li Daojuan, et al. Research progress of lung cancer screening in the population [J]. /OL].Cancer in China: 1-8.

[4] He Jie, Li Ni, Chen Wanqing, et al. Guidelines for screening, early diagnosis and early treatment of lung cancer in China (2021,Beijing) [J]. Chinese Journal of Cancer, 2021, 43(03):243-268.

[5] Yang Yabing, Tian Feng. Research progress in targeted therapy and immunotherapy of small cell lung cancer [J].Cancer progress, 2020, 18(14):1424-1426.

[6] Gao Yating, Wu Di,Li Zegeng, et al. Meta analysis of the impact of integrated traditional Chinese and western medicine intervention therapy on the quality of life of lung cancer patients [J]. World Science and Technology Modernization of Traditional Chinese Medicine,2020,22(07):2246-2255.

[7] Oncology Branch of the Chinese Medical Association, Journal of the Chinese Medical Association. Guidelines for Clinical Diagnosis and Treatment of Lung Cancer of the Chinese Medical Association (2022 Edition) [J].Chinese Medical Journal, 2022, 102(23) : 1706-1740.

[8] Lin Hongsheng, Liu Jie, Zhang Ying The connotation and significance of the Chinese Medical Diagnosis and Treatment Guide for Malignant Tumor [J]. Clinical and Rehabilitation of Cancer in China, 2016, 23(03):257-260.

[9] Tan Zhaofeng, Qi Yuanfu, Xia Lei, et al. Treating tumor diseases from phlegm [J].Journal of Traditional Chinese Medicine, 2018,33(11):2053-2056.

[10] Yang Bian, Xie Baozhong. Research on the relationship between four TCM constitutional biases and tumor screening and rehabilitation [J]. Journal of Traditional Chinese Medicine, 2010, 51(S2): 169.

[11] Li Xianli, Ma Jianling, Zhang Jingfeng, et al. Clinical practice of differentiation and treatment of convalescent novel coronavirus pneumonia based on the theory of "lung spleen correlation" [J].Liaoning Journal of Traditional Chinese Medicine, 2022, 49(02): 25-28+221.

[12] Zhu Qingjun. Effect of the volatile oil of Atractylodes macrocephala on the proliferation and cell cycle of human lung cancer cell line PG [J].Science and Technology of Traditional Chinese Medicine, 2008, 15(06):428-429.

[13] Tang Xiaoyong, Tang Yingxue, Xu Peng, et al. Effect of Zhebeinmei on nucleotide ERCC1 gene and LRP expression in A549 /cisplatin resistant lung cancer cell line [J]. Chinese Journal of Integrated Traditional and Western Medicine, 2015,35(12):1490-1494.

[14] Ruan Mengling, Zhao Yongxin, Wei Lili, et al. Effect of Erchen Decoction on anorexia of advanced lung cancer with phlegm dampness syndrome [J].Inner Mongolia Traditional Chinese Medicine, 2022, 41(07): 44-45.